Publications by authors named "Bernardo M Dell'Osso"

Article Synopsis
  • Treatment-Resistant Depression (TRD) affects about 30% of people with Major Depressive Disorder, and a new nasal spray called Esketamine (ESK-NS) has been approved to help treat it when combined with certain medications.
  • Researchers wanted to see if combining Vortioxetine, another antidepressant, with ESK-NS was just as good or better than the usual treatment.
  • The results showed that the Vortioxetine and ESK-NS combo worked well to reduce depression and had fewer side effects, suggesting it could be a better option, but more research is needed to be sure.
View Article and Find Full Text PDF
Article Synopsis
  • Treatment-Resistant Depression (TRD) is a significant health issue that's hard to tackle due to its complex nature and varied symptoms, prompting the need for better treatment strategies.
  • The SelecTool Project is introduced as a computational tool that combines clinical data, EEG, and blood biomarkers using machine learning to personalize TRD treatments, specifically focusing on esketamine nasal spray and accelerated repetitive Transcranial Magnetic Stimulation.
  • The project involves two main phases: first, a study with 100 TRD subjects to evaluate the effectiveness of treatments, and then training the tool to assist in managing an additional 20 subjects, ultimately aiming to improve TRD treatment outcomes through advanced data analysis.
View Article and Find Full Text PDF

Objective: People with mental illness are overrepresented throughout the criminal justice system. In Italy, the Judicial Psychiatric Hospitals are now on the edge of their closure in favor of small-scale therapeutic facilities (REMS). Therefore, when patients end their duty for criminal behaviors, their clinical management moves back to the outpatient psychiatric centers.

View Article and Find Full Text PDF

Obsessive-compulsive disorder (OCD) is a chronic disease with a prevalence in the general population of around 2%-3%, generally accompanied by a severe impairment of functioning and quality of life. A consistent subgroup of patients may not achieve adequate symptom remission with first-line treatments (i.e.

View Article and Find Full Text PDF

Climate change is one of the main global challenges and influences various aspects of human health. Numerous studies have indeed demonstrated an association between extreme climate-related events and physical and mental health outcomes, but little is still known about the association between the perception/awareness of climate change and mental health. In accordance with the PRISMA 2020 guidelines, a search was conducted on PubMed and Scopus.

View Article and Find Full Text PDF

Introduction: Intravenous ketamine (KET-IV) and intranasal esketamine (ESK-NS) are effective in the acute treatment of Treatment-Resistant Depression (TRD). Studies comparing KET-IV and ESK-NS concerning their action, safety, and tolerability are currently lacking.

Materials And Methods: We combined patients' data from two unipolar TRD cohorts that received KET-IV (n = 171) at the Canadian Rapid Treatment Center of Excellence in Toronto, Canada, or ESK-NS (n = 140) at several TRD clinics in Italy.

View Article and Find Full Text PDF

In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention.

View Article and Find Full Text PDF